Oral Veterinary Pain Management Drugs Market

The global Oral Veterinary Pain Management Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Opioids Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Oral Veterinary Pain Management Drugs include Boehringer Ingelheim, Merck & Co, Zoetis, Elanco, Bayer Pharma AG, Ceva Sante Animale, Norbrook Laboratories, Baxter and Halyard, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Oral Veterinary Pain Management Drugs Market aims to provide a comprehensive presentation of the global market for Oral Veterinary Pain Management Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Veterinary Pain Management Drugs. Oral Veterinary Pain Management Drugs Market contains market size and forecasts of Oral Veterinary Pain Management Drugs in global, including the following market information:
Global Oral Veterinary Pain Management Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Oral Veterinary Pain Management Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Veterinary Pain Management Drugs Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Oral Veterinary Pain Management Drugs Market Segment Percentages, by Type, 2023 (%)
Opioids
?2-Adrenergic Agonists
Local Anesthetics
Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
Sedatives
Other
Global Oral Veterinary Pain Management Drugs Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Oral Veterinary Pain Management Drugs Market Segment Percentages, by Application, 2023 (%)
Veterinary Hospitals
Veterinary Clinics
For Retail
Others
Global Oral Veterinary Pain Management Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Oral Veterinary Pain Management Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Veterinary Pain Management Drugs revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Oral Veterinary Pain Management Drugs revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim
Merck & Co
Zoetis
Elanco
Bayer Pharma AG
Ceva Sante Animale
Norbrook Laboratories
Baxter
Halyard
Bostonscientific
Lilly
Endo International
Forest Laboratories
Medtronic
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Veterinary Pain Management Drugs, market overview.
Chapter 2: Global Oral Veterinary Pain Management Drugs market size in revenue.
Chapter 3: Detailed analysis of Oral Veterinary Pain Management Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Veterinary Pain Management Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.